Registrieren

Registierung erfolgt in Kürze...
Fleebs-Logo
Details werden geladen...

Spyre Therapeutics to Participate in Upcoming June Investor Conferences | The Manila Times

WALTHAM, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease ('IBD”) and rheumatic diseases, today announced that management will participate in the following upcoming investor conferences: